FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approves a supplemental application for Cerebyx (fosphenytoin sodium) from Pfizer Laboratories Div Pfizer Inc, updating labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Drugs mentioned

• CEREBYX (FOSPHENYTOIN SODIUM)

Snippet

SUPPL AP for CEREBYX (FOSPHENYTOIN SODIUM)